Timothy Hoey
Direttore Tecnico/Scientifico/R&S presso TENAYA THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Posizioni attive di Timothy Hoey
Società | Posizione | Inizio | Fine |
---|---|---|---|
TENAYA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2017 | - |
Storia della carriera di Timothy Hoey
Precedenti posizioni note di Timothy Hoey
Società | Posizione | Inizio | Fine |
---|---|---|---|
ONCOMED PHARMACEUTICALS INC | Direttore Tecnico/Scientifico/R&S | 01/01/2016 | 01/01/2017 |
Corporate Officer/Principal | 01/01/2005 | 01/01/2016 | |
AMGEN INC. | Corporate Officer/Principal | - | 01/01/2005 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | - | 14/12/2011 |
Corporate Officer/Principal | 14/12/2011 | - |
Formazione di Timothy Hoey
The Trustees of Columbia University in The City of New York | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
AMGEN INC. | Health Technology |
TENAYA THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
OncoMed Pharmaceuticals, Inc.
OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Borsa valori
- Insiders
- Timothy Hoey
- Esperienza